Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 247.60
Bid: 247.20
Ask: 247.60
Change: -2.40 (-0.96%)
Spread: 0.40 (0.162%)
Open: 252.00
High: 252.00
Low: 247.20
Prev. Close: 250.00
CTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ConvaTec Acquisition of Woodbury Holdings

20 Jul 2017 07:00

RNS Number : 5616L
ConvaTec Group PLC
20 July 2017
 

Acquisition of Woodbury Holdings

 

 

Reading, United Kingdom (20 July 2017) 

 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, has agreed to acquire Woodbury Holdings ("Woodbury" or "The Company"), a US-based independent national distributor of incontinence and catheter-related supplies, from MTS Health Investors LLC for an enterprise value of $120.5 million.

 

Woodbury provides an extensive array of incontinence and catheter products, as well as nutritional, enteral feeding and vascular compression supplies. The Company has national distribution across the U.S., delivering directly to customers in the home environment.

 

With this acquisition ConvaTec Americas will create a new home distribution business unit for catheter and incontinence related products, encapsulating the U.S. distribution companies of 180 Medical, Symbius Medical, South Shore Medical Supply, Wilmington Medical Supply and Woodbury Health Products.

 

"The addition of Woodbury contributes to our growth strategy for the Continence & Critical Care Franchise and builds on the success of our 180 Medical business, which we acquired in 2012. 180 Medical is the largest retailer of intermittent catheters in the U.S. It has a differentiated, proven business model with strong customer focus and satisfaction," said Paul Moraviec, Chief Executive Officer of ConvaTec. "The addition of Woodbury will provide further breadth and reach to our new Home Distribution Group and further consolidate our leading position in this market, expand customer relationships and provide greater choice direct to US consumers."

 

"ConvaTec, 180 Medical and Woodbury share a common commitment to improving the lives of people with continence issues and a dedication to providing quality products, together with distinctive service and personal support. We look forward to working with our Woodbury colleagues to bring our comprehensive end-to-end suite of services to even more customers."

 

Woodbury's senior management team will remain with the Company.

 

Upon completion of the transaction, earnings from Woodbury Holdings will be immediately accretive to the financial accounts of ConvaTec Group Plc.

 

Enquiries

 

Analysts and Investors

 

John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582

investorrelations@convatec.com

 

Media

 

Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226

Alastair Elwen, Finsbury +44 (0)207 251 3801

 

About ConvaTec

 

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 

About Woodbury Holdings

 

Woodbury, founded in 1977 and headquartered in Floral Park, NY, focuses on solving the individual needs of customers with incontinence or other urological conditions. Through its subsidiaries Woodbury Health Products and Wilmington Medical Supply, Inc., the company offers a broad product portfolio of over 500 incontinence and over 650 catheter products, and a wide array of nutritional, enteral feeding and vascular compression products. Woodbury operates with 149 employees, a centralised distribution centre in Wilmington NC and a primary call centre in Bunnell, FL. Woodbury's differentiated engagement and delivery model provides customers with a tailored and seamless solution they can depend on - the right product the right time, the right place. www.woodburyproducts.com / www.wmsuro.com

 

# # #

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAKXNFDFXEFF
Date   Source Headline
13th Sep 202212:08 pmEQSConvatec Group PLC: Scrip Dividend – Calculation Price
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
4th Aug 20227:00 amRNSInterim Results
7th Jul 202211:53 amRNSDirector Declaration
28th Jun 20225:26 pmRNSBlock listing Interim Review
31st May 20222:00 pmRNSTotal Voting Rights
19th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20224:25 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update
4th May 20223:31 pmRNSScrip Dividend - Total Issued Shares
3rd May 20227:00 amRNSNotice of Forthcoming Scheduled IR Events
7th Apr 20223:45 pmRNSScrip Dividend – Calculation Price
1st Apr 20224:00 pmRNSHolding(s) in Company
31st Mar 20223:45 pmRNSTotal Voting Rights
30th Mar 202212:00 pmRNSAnnual Report and Accounts 2021 and Notice of AGM
25th Mar 20222:00 pmRNSDirector/PDMR Shareholding
23rd Mar 202211:30 amRNSDirector/PDMR Shareholding
17th Mar 20222:40 pmRNSDirector/PDMR Shareholding
17th Mar 20222:20 pmRNSBoard Change
14th Mar 20227:00 amRNSAcquisition Completion of Triad Life Sciences Inc
8th Mar 20227:00 amRNSAnnual Results
28th Feb 202211:00 amRNSNon-Executive Director Changes
10th Feb 20223:15 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSAcquisition: entry into attractive wound biologics
27th Jan 202211:00 amRNSBoard Committee Changes
20th Dec 20218:45 amRNSBlock Listing Application
16th Dec 20212:00 pmRNSNon-Executive Director appointment
9th Dec 20217:00 amRNSChief Financial Officer succession
1st Nov 20213:35 pmRNSTotal Voting Rights
29th Oct 20217:00 amRNSQ3 Trading Update
18th Oct 20214:30 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPricing of $500M 3.875% Senior Notes due 2029
30th Sep 20211:13 pmRNSConvaTec Announces Offer of $500M Senior Notes
28th Sep 20213:15 pmRNSScrip Dividend - Total Issued Shares
9th Sep 20213:00 pmRNSScrip Dividend - Calculation Price
30th Jul 20213:45 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSInterim Results
28th Jun 202112:40 pmRNSDirector Declaration
1st Jun 202111:45 amRNSTotal Voting Rights
17th May 20213:15 pmRNSDirector/PDMR Shareholding
7th May 20212:50 pmRNSResult of AGM
29th Apr 20217:00 amRNSQ1 Trading Update
28th Apr 202112:45 pmRNSScrip Dividend - Total Issued Shares
12th Apr 20213:15 pmRNSScrip Dividend - Calculation Price
22nd Mar 20213:40 pmRNSAnnual Report and Accounts 2020 and Notice of AGM
11th Mar 20213:50 pmRNSDirector/PDMR Shareholding
5th Mar 20217:00 amRNSAnnual Results
22nd Feb 202111:30 amRNSDirector Declaration
21st Dec 202011:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.